Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CCO Tommi Manninen joins Summa Defence's management team

Press release November 7, 2024, at 09:00     Tommi Manninen, who has long been influential in the media and communications sector, has been appointed as Chief Communications Officer and member of the management team at Summa Defence Oy.    Manninen has previously worked in his career as  Senior Vice President, Communications and Public Affairs at the listed company Enersense International Oyj, and as Chief Content Officer at Kreab, a communications agency specializing in financial and investor communications, and has participated in several stock market listings and corporate

ZWIPE AS – Q3 2024 Operational Update

OSLO, NORWAY – 7 November 2024 - During the third quarter, Zwipe experienced a significant positive development by signing several Proof-of-Concept (PoC) projects.   Significant events during the quarter   ▐       Zwipe announced that one of the world’s top digital music streaming service providers is currently testing Zwipe’s biometric access cards. This evaluation is part of a potential deployment of Zwipe’s technology across the company.   ▐       A leading U.S.-based social media and IT company is currently testing Zwipe Access biometric cards via their strategic

Finnair Traffic Performance in October 2024

Finnair Plc                 Investor News               7 November 2024 at 9:00 a.m. EET The number of passengers again crossed above one million and increased more than capacity – both passenger load factor and on-time performance improved In October, Finnair carried 1,020,000 passengers, which was 10.8% more than in October 2023. The overall capacity, measured in Available Seat Kilometres (ASK), increased in October by 6.6% year-on-year, as additional narrow-body capacity was deployed by Finnair after the wet lease outs to British Airways ended in March 2024. In addition, the

Optomed Plc: Interim Report, January – September 2024

Optomed Plc Stock Exchange Release 7 November 2024 at 9.00, Helsinki Optomed Plc: Interim Report, January – September 2024 July – September 2024 · Revenue decreased by 26.3 percent to EUR 3.1 (4.2) million against a strong comparison period of Q3-2023 that was supported by a Device segment delivery to Spain worth approximately EUR 0.8 million and a large delivery to China · Devices segment revenue decreased by 55.5 percent to EUR 0.8 (1.8) million. Without the Q3 2023  one-time deal in Spain, the revenue would have decreased EUR 0.2 million. · Software segment revenue

Sitowise Group Plc's financial reporting and Annual General Meeting in 2025

Sitowise Group Plc                    Stock Exchange Release           7 November 2024                     at 9.00 a.m. EET Sitowise Group Plc will publish financial reports in 2025 as follows: Publishing dateFinancial Statements Release for 2024 12 February 2025Annual Report 2024 week 11, 2025Interim Report for January-March 2025 13 May 2025Half-Year Report for January-June 2025 13 August 2025Interim Report for January-September 2025 6 November 2025 The financial reports are planned to be

UNION therapeutics to present at the 8th Annual Dermatology Drug Development Summit in Boston

Hellerup, Denmark, November 7, 2024 – UNION therapeutics A/S (UNION), a privately held, clinical stage, pharmaceutical development company focused on immunology, today announced that Dr. Kim Kjøller, CO-CEO of UNION will present at the seminar on Clinical and Commercial Strategy at the 8th Annual Dermatology Drug Development Summit on 12-14 November 2024, in Boston, US.   Dr. Kjøller will discuss recent trials in atopic dermatitis (AD) and the ability between outcome scales to adequately differentiate between placebo and active treatment, particularly in the segment of patients with

Future-oriented focus while adapting to a weak market

Press Release Kostrzyn nad Odra / Gothenburg, November 7th, 2024 Arctic Paper S.A., Q3, 2024: •     Q3 consolidated sales revenue amounted to PLN 819.3mn (EUR1 190.3mn). •     EBITDA in Q3 was PLN 77.3mn (EUR1 18.0mn). •     EBIT in Q3 was PLN 47.5mn (EUR1 11.0mn) and net profit PLN 36.6mn (EUR1 8.5mn). •     Focus on the right balance between capacity usage and margins. •     A 9.6 MW expansion of the PV farm in Kostrzyn began during the period. •     Net debt PLN -27.5mn (PLN -306.7mn) with a net debt/EBITDA at -0.08 (-0.59).     “The recovery in our main

Musti remains resilient, growing the number of customers

Musti Group plc                Interim Report            7 November 2024 at 8:30 a.m. EET Musti Group plc Interim Report 1 October 2023 – 30 September 2024 Musti remains resilient, growing the number of customers   July  – September 2024  · Group net sales totaled EUR 111.5 (110.4) million, an increase of 1.0% (8.4%). · Like-for-like sales decreased by 0.9%. · Adjusted EBITDA was EUR 16.5 (20.6) million. · Adjusted EBITDA margin was 14.8% (18.7%). · Adjusted EBITA was EUR 7.8 (12.6) million. · Adjusted EBITA margin was 7.0% (11.4%). · Net cash flow from

Anora Group Plc’s Interim Report January–September 2024: All segments improved their gross margins in Q3, lower volumes in beverage sales had a negative impact on comparable EBITDA

Anora Group Plc   Interim report    7 November 2024 at 8:30 am EET Anora Group Plc’s Interim Report January–September 2024: All segments improved their gross margins in Q3, lower volumes in beverage sales had a negative impact on comparable EBITDA This release is a summary of Anora Group Plc's Interim Report January–September 2024. The complete report is attached to this release and is also available on the company website at: www.anora.com/en/investors Q3 2024 in brief · Net sales were EUR 162.7 (173.0) million, down by 6.0%. · Comparable EBITDA was EUR 15.9 (20.2) million,

Cinis Fertilizer investigates the possibility to issue senior secured green bonds, publishes preliminary figures, selected financials and establishes a Green Finance Framework

Cinis Fertilizer is investigating the possibility of issuing senior secured callable green bonds in an expected amount of SEK 550 million. In connection with the contemplated issuance of bonds, Cinis publishes certain preliminary figures for the third quarter of 2024 and selected financials as of 31 October 2024, as well as establishes a Green Finance Framework.Cinis Fertilizer AB (publ) (the "Company") hereby announces that it has mandated ABG Sundal Collier AB, Nordea Bank Abp and Pareto Securities AB as joint bookrunners to investigate the possibility of issuing new senior secured

Checkin.com Group Quarterly Report Q3 2024

Checkin.com Group (STO:CHECK) reports a challenging quarter, but positive long-term outlook remains. The report in brief: Q3 2024 (vs Q3 2023):· Net revenue decreased to KSEK 18,646 (29,947) which corresponds to a growth of -38 (76)%, of which -38 (76)% was organic. · Gross profit for the period amounted to KSEK 13,646 (25,062) with a margin of 73 (84)%. · EBITDA for the period amounted to KSEK 4,259 (10,881) with a margin of 23 (36)%. · Cash flow from operating activities amounted to KSEK 2,023 (7,650). · Net Revenue Retention LTM amounted to 58 (173)%. · Cash and cash

Rugvista Group AB (publ) – publishes Interim Report for January – September 2024

Challenging market and comparables Third quarter · Net revenue was SEK 144.8 (159.6) million, corresponding to a decrease of -9.3% (24.7%). · Organic net revenue growth was -7.1% (14.1%). · The gross margin amounted to 62.4% (62.7%). · The operating profit amounted to SEK 9.0 (18.6) million, and the operating margin was 6.2% (11.7%). · The profit for the period was SEK 7.9 (15.2) million. · Earnings per share before and after dilution amounted to SEK 0.38 (0.73). · The average NPS (Net Promoter Score) was 62 (68), and the average Trustpilot rating was 4.7 (4.8).

Sitowise's Interim Report Q3 2024: Determined actions for better future profitability

Sitowise Group Plc, Interim Report, 1 January – 30 September 2024, 7 November 2024 at 8:30 am EET This release is a summary of Sitowise Group Plc’s Interim Report January–September 2024. The complete report is attached to this release as a PDF file, and also available on the company’s website at www.sitowise.com/investors/reports-and-presentations July–September in brief · Net sales decreased by 8.4% to EUR 41.8 (45.6) million. In constant currency net sales were down by 8.3%. · Organic net sales growth was negative at -10.5% (1.0%). · Adjusted EBITA was EUR 2.4 (3.5)

Moody's reaffirms Rikshem's rating A3, with stable outlook

The credit rating agency Moody's Ratings reaffirms Rikshem's strong credit rating of A3 with a stable outlook.The strong credit rating shows Rikshem's stable position with a qualitative portfolio of residential rental apartments and properties for public use in the healthcare and education sectors. Moody's highlights the good rental growth, high occupancy rate, long average remaining lease term for properties for public use, very good liquidity coverage and Rikshem's strong ownership support as reasons for the credit rating. "The credit rating confirms what we ourselves experience - a

Asetek – Q3 2024: Soft quarter as expected – continued strong progress in SimSports

· Q3 revenue of $12.2 million, compared with $20.5 million in Q3 2023 · Gross margin of 36%, compared with 46% in Q3 2023, due to supply chain quality issue that has since been rectified · Q3 EBITDA adjusted of ($0.5) million compared with $4.8 million in Q3 2023 · Net income is impacted by $18 million of non-cash write downs and $0.8 million U.S. tax cost · Year-to-date revenue of $37.1 million and adjusted EBITDA of ($0.3) million, compared with $59.7 million and $13.7 million in the same periods of 2023, respectively · SimSports with significant commercial progress,

Flex LNG secures Time Charter extension for Flex Courageous and Flex Resolute by up to 10 years from 2029

Hamilton, Bermuda November 7, 2024   Flex LNG Ltd (“Flex LNG” or the “Company”) (NYSE/OSE: FLNG) is pleased to announce it has agreed with the Charterer of Flex Courageous and Flex Resolute, a Supermajor, to amend the existing Time Charter Agreements (“TC”) for the two LNG carriers where the parties have agreed a new firm period from 2029 to 2032 which may be extended by an additional seven years in total until 2039.   As communicated by the Company on November 1, 2021, Flex LNG and the Charterer then agreed TCs for the two ships with commencement during the first quarter of

CapMan Plc 1–9 2024 Interim Report

CapMan PlcStock Exchange Release / Q3 Interim Report7 November 2024 at 8:00 a.m. EET CapMan Plc 1–9 2024 Interim Report Results for continuing operations and significant events in 1–9 2024: CapMan classifies CaPS business as a discontinued operation in the income statement and the comparison periods' figures are restated accordingly. · Assets under management EUR 6.0 billion 30 September 2024 (EUR 5.0 billion 31 December 2023). · Group turnover was MEUR 43.7 1 January–30 September 2024 (MEUR 37.9 1 January–30 September 2023). · Fee income was MEUR 39.9 (MEUR 34.9).

Clas Ohlson’s sales increased in October compared to the previous year

Net sales amounted to 972 MSEK (838), an increase by 16 per cent, of which 9 per cent relates to organic growth*, -2 per cent to currency effects and 8 per cent to sales in Spares Group. Compared with the same month of the preceding year, the store network increased by a net of 16 stores (reduction of 3 stores in the previous year). The total number of stores at the end of the period was 237.Total net sales for the period May-October 2024 amounted to 5,424 MSEK (4,653), an increase by 17 per cent compared with the corresponding period in the previous year, of which 9 per cent relates to

Clinical phase II trial of uPAR-PET in brain cancer patients published; data supports development of uTREAT for brain cancer

· Curasight’s radiopharmaceutical approach leverages the uPAR theranostic platform with the aim of providing improved diagnosis (uTRACE) and more gentle treatment (uTREAT) of certain types of cancers · Data from the Phase II uTRACE trial is now published in full in the peer-reviewed journal EJNMMI Research Copenhagen, Denmark, 7 November 2024 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) announces today that the investigator-initiated phase II study using uPAR-PET in brain cancer has been publishedThe investigator-initiated clinical trial testing [68]Ga-NOTA-AE105

New operating model implemented and cost measures deployed to drive improved profitability

Catena Media plc Interim Report January – September 2024 July-September 2024 · Revenue from continuing operations was EUR 10.7m (15.9), a decrease of 33 percent. · Revenue in North America decreased 29 percent to EUR 9.5m (13.3), equivalent to 89 percent (84) of group revenue from continuing operations. · New depositing customers (NDCs) from continuing operations totalled 27,342 (40,104), a decrease of 32 percent. · Adjusted EBITDA from continuing operations decreased 58 percent to EUR 1.3m (3.2), corresponding to an adjusted EBITDA margin of 13 percent (20). · EBITDA

Pihlajalinna Interim Report 1 January–30 September 2024: Solid development in organic growth and profitability

Pihlajalinna Plc                           Interim Report                            7 November 2024 at 8:00 a.m. Pihlajalinna Interim Report 1 January–30 September 2024 Solid development in organic growth and profitability This Interim Report is unaudited. The comparison figures in brackets refer to the corresponding period in the previous year. July–September in brief: · Revenue amounted to EUR 164.0 (165.6) million – a decrease of -1.0 per cent. · Comparable organic revenue growth[1)] was EUR 13.3 million, or 8.9 per cent. · In the Private Healthcare Services

There are no items matching the current filter
There are no more items matching the current filter
Back to top